Jelfa continues its growth and looks to take a larger share of the Russia market

Jelenia Gora-based pharmaceutical producer, Jelfa has opened a representative office in Moscow and may establish one in Ukraine by the end of the year. The company was able to weather the 1998 international financial crisis thanks to a strategy of strengthening its position on its main markets. In this way, Jelfa found new partners and introduced several new drugs onto the market. In 2001 exports reached nearly zl. 56 million, 23% of its overall sales. The company is currently working on some 50 new drugs. This year, Jelfa will invest around zl. 60 million, mainly in constructing a new laboratory and expand its quality control section. (Rzeczpospolita, p. B3) M.K.